Literature DB >> 9620302

Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms.

H S Oh1, R C Smart.   

Abstract

The epidermis is a stratified squamous epithelium composed primarily of keratinocytes that undergo sequential changes in gene expression during differentiation. CCAAT/enhancer binding proteins (C/EBP) are members of the bZIP family of DNA binding proteins/transcription factors. Northern analysis demonstrated that C/EBPalpha, C/EBPbeta, and C/EBPdelta mRNA are expressed in mouse epidermis and their mRNA levels were generally greater than those observed in other tissues known to express high levels of C/EBP. Western analysis of isolated epidermal cell nuclei demonstrated the presence of a 42 and 30 kDa C/EBPalpha protein and 35 kDa C/EBPbeta protein. Immunohistochemical localization of C/EBPalpha and C/EBPbeta in intact interfollicular epidermis revealed that C/EBPbeta expression is exclusive to the nuclei of a three-cell cluster of suprabasal keratinocytes that is morphologically consistent with the central column of the epidermal proliferative unit, and that C/EBPalpha is expressed in the nuclei and cytoplasm of suprabasal keratinocytes and weakly expressed in a perinuclear manner in some basal keratinocytes. In squamous cell carcinomas the expression of C/EBPalpha and C/EBPbeta was greatly diminished as both the intensity of nuclear staining and the number of cells expressing C/EBPalpha and C/EBPbeta were reduced. In isolated primary mouse keratinocytes, calcium-induced differentiation was accompanied by specific temporal changes in the expression of C/EBPalpha, C/EBPbeta, and C/EBPdelta mRNA and C/EBPalpha and C/EBPbeta protein. These results implicate a role for the C/EBP family in the regulation of genes involved in or specifically expressed during the process of squamous differentiation in epidermis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620302     DOI: 10.1046/j.1523-1747.1998.00199.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

1.  Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.

Authors:  Chrystelle Bonnart; Céline Deraison; Matthieu Lacroix; Yoshikazu Uchida; Céline Besson; Aurélie Robin; Anaïs Briot; Marie Gonthier; Laurence Lamant; Pierre Dubus; Bernard Monsarrat; Alain Hovnanian
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Authors:  Songyun Zhu; Kyungsil Yoon; Esta Sterneck; Peter F Johnson; Robert C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis.

Authors:  E Sterneck; S Zhu; A Ramirez; J L Jorcano; R C Smart
Journal:  Oncogene       Date:  2006-02-23       Impact factor: 9.867

4.  C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas.

Authors:  Elizabeth A Thompson; Songyun Zhu; Jonathan R Hall; John S House; Rakesh Ranjan; Jeanne A Burr; Yu-Ying He; David M Owens; Robert C Smart
Journal:  J Invest Dermatol       Date:  2011-02-24       Impact factor: 8.551

5.  C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.

Authors:  Kyungsil Yoon; Robert C Smart
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 6.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

7.  C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.

Authors:  Jonathan R Hall; Michael S Bereman; Angelito I Nepomuceno; Elizabeth A Thompson; David C Muddiman; Robert C Smart
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform.

Authors:  Ligia Selagea; Alok Mishra; Monika Anand; James Ross; Carol Tucker-Burden; Jun Kong; Daniel J Brat
Journal:  FASEB J       Date:  2016-08-29       Impact factor: 5.191

9.  C/EBPalpha and C/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin.

Authors:  John S House; Songyun Zhu; Rakesh Ranjan; Keith Linder; Robert C Smart
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.